array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_7975" } ["content_title"]=> array(1) { [0]=> string(13) "MARIA SANTORO" } ["description"]=> array(1) { [0]=> string(94781) "Inserire qui il curriculumInsert here the curriculum a:84:{i:0;a:14:{s:9:"citazione";s:260:"Lombardi, F., Giacomelli, A., Armenia, D., Lai, A., Dusina, A., Bezench, A., et al. (2020). Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS.";s:4:"data";s:10:"2020-11-28";s:2:"id";s:20:"PUBBLICAZIONE_406643";s:6:"handle";s:11:"2108/262457";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:121:"Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database.";s:9:"metadata6";s:206:"Lombardi, F; Giacomelli, A; Armenia, D; Lai, A; Dusina, A; Bezench, A; Timelli, L; Saladini, F; Vichi, F; Corsi, P; Colao, G; Bruzzone, B; Gagliardini, R; Callegaro, A; Castagna, A; Santoro, M; Group., ftAS";s:9:"metadata7";s:33:"10.1016/j.ijantimicag.2020.106252";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:281:"Santoro, M., Fornabaio, C., Malena, M., Galli, L., Poli, A., Menozzi, M., et al. (2020). Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS.";s:4:"data";s:7:"2020-07";s:2:"id";s:20:"PUBBLICAZIONE_406671";s:6:"handle";s:11:"2108/262459";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:145:"Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen.";s:9:"metadata6";s:119:"Santoro, M; Fornabaio, C; Malena, M; Galli, L; Poli, A; Menozzi, M; Zazzi, M; White, K; Castagna, A; PRESTIGIO Study, G";s:9:"metadata7";s:33:"10.1016/j.ijantimicag.2020.106027";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:255:"Bouba, Y., Berno, G., Fabeni, L., Carioti, L., Salpini, R., Aquaro, S., et al. (2020). Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(7), 1778-1786.";s:4:"data";s:10:"2020-03-11";s:2:"id";s:20:"PUBBLICAZIONE_384152";s:6:"handle";s:11:"2108/242536";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:110:"Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir";s:9:"metadata6";s:126:"Bouba, Y; Berno, G; Fabeni, L; Carioti, L; Salpini, R; Aquaro, S; Svicher, V; Perno, CF; Ceccherini-Silberstein, F; Santoro, M";s:9:"metadata7";s:19:"10.1093/jac/dkaa073";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:244:"Armenia, D., Di Carlo, D., Flandre, P., Bouba, Y., Borghi, V., Forbici, F., et al. (2020). HIV MDR is still a relevant issue despite its dramatic drop over the years. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(5), 1301-1310 [10.1093/jac/dkz554].";s:4:"data";s:10:"2020-01-24";s:2:"id";s:20:"PUBBLICAZIONE_384209";s:6:"handle";s:11:"2108/242573";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:74:"HIV MDR is still a relevant issue despite its dramatic drop over the years";s:9:"metadata6";s:356:"Armenia, D; Di Carlo, D; Flandre, P; Bouba, Y; Borghi, V; Forbici, F; Bertoli, A; Gori, C; Fabeni, L; Gennari, W; Pinnetti, C; Mondi, A; Cicalini, S; Gagliardini, R; Vergori, A; Bellagamba, R; Malagnino, V; Montella, F; Colafigli, M; Latini, A; Marocco, R; Licthner, M; Andreoni, M; Mussini, C; Ceccherini Silberstein, F; Antinori, A; Perno, CF; Santoro, M";s:9:"metadata7";s:18:"10.1093/jac/dkz554";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:289:"Soulie, C., Santoro, M.M., Storto, A., Abdi, B., Charpentier, C., Armenia, D., et al. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY.";s:4:"data";s:10:"2020-01-24";s:2:"id";s:20:"PUBBLICAZIONE_374497";s:6:"handle";s:11:"2108/233895";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:155:"Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy";s:9:"metadata6";s:228:"Soulie, C; Santoro, MM; Storto, A; Abdi, B; Charpentier, C; Armenia, D; Jary, A; Forbici, F; Bertoli, A; Gennari, W; Andreoni, M; Mussini, C; Antinori, A; Perno, CF; Calvez, V; Ceccherini-Silberstein, F; Descamps, D; Marcelin, A";s:9:"metadata7";s:18:"10.1093/jac/dkz553";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:5;a:14:{s:9:"citazione";s:327:"Alteri, C., Scutari, R., Stingone, C., Maffongelli, G., Brugneti, M., Falasca, F., et al. (2019). Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success. JOURNAL OF CLINICAL VIROLOGY, 117, 61-67.";s:4:"data";s:10:"2019-07-14";s:2:"id";s:20:"PUBBLICAZIONE_354579";s:6:"handle";s:11:"2108/217249";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:186:"Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success";s:9:"metadata6";s:214:"Alteri, C; Scutari, R; Stingone, C; Maffongelli, G; Brugneti, M; Falasca, F; Martini, S; Bertoli, A; Turriziani, O; Sarmati, L; Coppola, N; Andreoni, M; Santoro, MM; Perno, C-; Ceccherini-Silberstein, F; Svicher, V";s:9:"metadata7";s:25:"10.1016/j.jcv.2019.06.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:6;a:14:{s:9:"citazione";s:267:"Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., et al. (2019). Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy. SEXUALLY TRANSMITTED INFECTIONS, 95(8), 619-625.";s:4:"data";s:10:"2019-05-10";s:2:"id";s:20:"PUBBLICAZIONE_354585";s:6:"handle";s:11:"2108/217254";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:129:"Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy";s:9:"metadata6";s:377:"Fabeni, L; Alteri, C; Berno, G; Scutari, R; Orchi, N; De Carli, G; Bertoli, A; Carioti, L; Gori, C; Forbici, F; Salpini, R; Vergori, A; Gagliardini, R; Cicalini, S; Mondi, A; Pinnetti, C; Mazzuti, L; Turriziani, O; Colafigli, M; Borghi, V; Montella, F; Pennica, A; Lichtner, M; Girardi, E; Andreoni, M; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:28:"10.1136/sextrans-2019-054017";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:7;a:14:{s:9:"citazione";s:265:"Armenia, D., Di Carlo, D., Cozzi-Lepri, A., Calcagno, A., Borghi, V., Gori, C., et al. (2019). Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. ANTIVIRAL THERAPY, 24(5), 321-331.";s:4:"data";s:10:"2019-04-12";s:2:"id";s:20:"PUBBLICAZIONE_354587";s:6:"handle";s:11:"2108/217256";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:134:"Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen";s:9:"metadata6";s:349:"Armenia, D; Di Carlo, D; Cozzi-Lepri, A; Calcagno, A; Borghi, V; Gori, C; Bertoli, A; Gennari, W; Bellagamba, R; Castagna, A; Latini, A; Pinnetti, C; Cicalini, S; Saracino, A; Lapadula, G; Rusconi, S; Castelli, F; Di Giambenedetto, S; Andreoni, M; Di Perri, G; Antinori, A; Mussini, C; Ceccherini-Silberstein, F; Monforte, AD; Perno, CF; Santoro, MM";s:9:"metadata7";s:15:"10.3851/IMP3309";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:8;a:14:{s:9:"citazione";s:279:"Antinori, A., Santoro, M.m., Gagliardini, R., Marchetti, G., Mondi, A., Cento, V., et al. (2019). Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients. NEW MICROBIOLOGICA, 42(2), 69-80.";s:4:"data";s:10:"2019-02-20";s:2:"id";s:20:"PUBBLICAZIONE_346637";s:6:"handle";s:11:"2108/211319";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients";s:9:"metadata6";s:98:"Antinori, A; Santoro, Mm; Gagliardini, R; Marchetti, G; Mondi, A; Cento, V; Perno, Cf; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:9;a:14:{s:9:"citazione";s:251:"Alteri, C., Scutari, R., Bertoli, A., Armenia, D., Gori, C., Fabbri, G., et al. (2019). Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice. VIRUS GENES [10.1007/s11262-019-01649-z].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_345601";s:6:"handle";s:11:"2108/210456";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice";s:9:"metadata6";s:230:"Alteri, C; Scutari, R; Bertoli, A; Armenia, D; Gori, C; Fabbri, G; Mastroianni, Cm; Cerva, C; Cristaudo, A; Vicenti, I; Bruzzone, B; Zazzi, M; Andreoni, M; Antinori, A; Svicher, V; Ceccherini-Silberstein, F; Perno, Cf; Santoro, Mm";s:9:"metadata7";s:26:"10.1007/s11262-019-01649-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:10;a:14:{s:9:"citazione";s:352:"Fokam, J., Sosso, S.M., Yagai, B., Billong, S.C., Djubgang Mbadie, R.E., Kamgaing Simo, R., et al. (2019). Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: Adolescents at high risk of virological failure in the era of "test and treat". AIDS RESEARCH AND THERAPY, 16(1), 36 [10.1186/s12981-019-0252-0].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_384239";s:6:"handle";s:11:"2108/242597";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:178:"Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: Adolescents at high risk of virological failure in the era of "test and treat"";s:9:"metadata6";s:229:"Fokam, J; Sosso, SM; Yagai, B; Billong, SC; Djubgang Mbadie, RE; Kamgaing Simo, R; Edimo, SV; Nka, AD; Tiga Ayissi, A; Yimga, JF; Takou, D; Moudourou, S; Ngo Nemb, M; Nfetam Elat, J-; Santoro, M-; Perno, C-; Colizzi, V; Ndjolo, A";s:9:"metadata7";s:25:"10.1186/s12981-019-0252-0";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:11;a:14:{s:9:"citazione";s:296:"Pouga, L., Santoro, M.m., Charpentier, C., Di Carlo, D., Romeo, I., Artese, A., et al. (2019). New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T). CHEMICAL BIOLOGY & DRUG DESIGN, 93(1), 50-59 [10.1111/cbdd.13378].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_357397";s:6:"handle";s:11:"2108/219575";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:133:"New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)";s:9:"metadata6";s:215:"Pouga, L; Santoro, Mm; Charpentier, C; Di Carlo, D; Romeo, I; Artese, A; Alcaro, S; Antinori, A; Wirden, M; Perno, Cf; Ambrosio, Fa; Calvez, V; Descamps, D; Marcelin, A-; Ceccherini-Silberstein, F; Lambert-Niclot, S";s:9:"metadata7";s:18:"10.1111/cbdd.13378";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:12;a:14:{s:9:"citazione";s:259:"Rusconi, S., Santoro, M.m., Gianotti, N., Antinori, A., Bonora, S., Cingolani, A., et al. (2019). Is the rate of virological failure to cART continuing to decline in recent calendar years?. JOURNAL OF CLINICAL VIROLOGY, 116, 23-28 [10.1016/j.jcv.2019.04.009].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_362676";s:6:"handle";s:11:"2108/223843";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:90:"Is the rate of virological failure to cART continuing to decline in recent calendar years?";s:9:"metadata6";s:152:"Rusconi, S; Santoro, Mm; Gianotti, N; Antinori, A; Bonora, S; Cingolani, A; Ceccherini Silberstein, F; Tavelli, A; d'Arminio Monforte, A; Cozzi-Lepri, A";s:9:"metadata7";s:25:"10.1016/j.jcv.2019.04.009";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:13;a:14:{s:9:"citazione";s:370:"Takou, D., Fokam, J., Teto, G., Santoro, M.-., Ceccherini-Silberstein, F., Nanfack, A.J., et al. (2019). HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in Cameroon. BMC INFECTIOUS DISEASES, 19(1), 246 [10.1186/s12879-019-3871-0].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_379708";s:6:"handle";s:11:"2108/238632";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:199:"HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in Cameroon";s:9:"metadata6";s:198:"Takou, D; Fokam, J; Teto, G; Santoro, M-; Ceccherini-Silberstein, F; Nanfack, AJ; Sosso, SM; Dambaya, B; Salpini, R; Billong, SC; Gori, C; Fokunang, CN; Cappelli, G; Colizzi, V; Perno, C-; Ndjolo, A";s:9:"metadata7";s:25:"10.1186/s12879-019-3871-0";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:14;a:14:{s:9:"citazione";s:230:"Alteri, C., Fabeni, L., Scutari, R., Berno, G., Di Carlo, D., Gori, C., et al. (2018). Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence. SCIENTIFIC REPORTS, 8(1), 15739.";s:4:"data";s:10:"2018-10-24";s:2:"id";s:20:"PUBBLICAZIONE_339796";s:6:"handle";s:11:"2108/205572";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:109:"Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence";s:9:"metadata6";s:287:"Alteri, C; Fabeni, L; Scutari, R; Berno, G; Di Carlo, D; Gori, C; Bertoli, A; Vergori, A; Mastrorosa, I; Bellagamba, R; Mussini, C; Colafigli, M; Montella, F; Pennica, A; Mastroianni, CM; Girardi, E; Andreoni, M; Antinori, A; Svicher, V; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:26:"10.1038/s41598-018-34058-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:15;a:14:{s:9:"citazione";s:380:"Raffaelli, C.S., Rossetti, B., Paglicci, L., Colafigli, M., Punzi, G., Borghi, V., et al. (2018). Impact of transmitted HIV-1 drug resistance on the efficacy of firstline antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(9), 2480-2484 [10.1093/jac/dky211].";s:4:"data";s:7:"2018-09";s:2:"id";s:20:"PUBBLICAZIONE_384667";s:6:"handle";s:11:"2108/243359";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:203:"Impact of transmitted HIV-1 drug resistance on the efficacy of firstline antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor";s:9:"metadata6";s:156:"Raffaelli, CS; Rossetti, B; Paglicci, L; Colafigli, M; Punzi, G; Borghi, V; Pecorari, M; Santoro, M; Penco, G; Antinori, A; Zazzi, M; De Luca, A; Zanelli, G";s:9:"metadata7";s:18:"10.1093/jac/dky211";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:16;a:14:{s:9:"citazione";s:247:"Armenia, D., Zaccarelli, M., Borghi, V., Gennari, W., Di Carlo, D., Giannetti, A., et al. (2018). Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment. JOURNAL OF CLINICAL VIROLOGY, 104, 61-64.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_357405";s:6:"handle";s:11:"2108/219583";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:106:"Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment";s:9:"metadata6";s:248:"Armenia, D; Zaccarelli, M; Borghi, V; Gennari, W; Di Carlo, D; Giannetti, A; Forbici, F; Bertoli, A; Gori, C; Fabeni, L; Pinnetti, C; Marocco, R; Latini, A; Ceccherini-Silberstein, F; Mastroianni, CM; Mussini, C; Antinori, A; Perno, CF; Santoro, MM";s:9:"metadata7";s:25:"10.1016/j.jcv.2018.04.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:17;a:14:{s:9:"citazione";s:305:"Fokam, J., Bellocchi, M.c., Armenia, D., Nanfack, A.j., Carioti, L., Continenza, F., et al. (2018). Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children. MEDICINE, 97(13), e0176 [10.1097/MD.0000000000010176].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_331661";s:6:"handle";s:11:"2108/198783";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:149:"Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children";s:9:"metadata6";s:239:"Fokam, J; Bellocchi, Mc; Armenia, D; Nanfack, Aj; Carioti, L; Continenza, F; Takou, D; Temgoua, Es; Tangimpundu, C; Torimiro, Jn; Koki, Pn; Fokunang, Cn; Cappelli, G; Ndjolo, A; Colizzi, V; Ceccherini-Silberstein, F; Perno, C-; Santoro, Mm";s:9:"metadata7";s:27:"10.1097/MD.0000000000010176";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:18;a:14:{s:9:"citazione";s:303:"Santoro, M., Di Carlo, D., Armenia, D., Zaccarelli, M., Pinnetti, C., Colafigli, M., et al. (2018). Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. ANTIVIRAL THERAPY, 23(3), 249-257 [10.3851/IMP3197].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_320500";s:6:"handle";s:11:"2108/189072";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:149:"Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice";s:9:"metadata6";s:222:"Santoro, M; Di Carlo, D; Armenia, D; Zaccarelli, M; Pinnetti, C; Colafigli, M; Prati, F; Boschi, A; Antoni, A; Lagi, F; Sighinolfi, L; Gervasoni, C; Andreoni, M; Antinori, A; Mussini, C; Perno, C; Borghi, V; Sterrantino, G";s:9:"metadata7";s:15:"10.3851/IMP3197";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:19;a:14:{s:9:"citazione";s:250:"Fabeni, L., Berno, G., Fokam, J., Bertoli, A., Alteri, C., Gori, C., et al. (2017). Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains. JOURNAL OF CLINICAL MICROBIOLOGY, JCM.00656-17 [10.1128/JCM.00656-17].";s:4:"data";s:10:"2017-07-12";s:2:"id";s:20:"PUBBLICAZIONE_317846";s:6:"handle";s:11:"2108/186616";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:94:"Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains";s:9:"metadata6";s:252:"Fabeni, L; Berno, G; Fokam, J; Bertoli, A; Alteri, C; Gori, C; Forbici, F; Takou, D; Vergori, A; Zaccarelli, M; Maffongelli, G; Borghi, V; Latini, A; Pennica, A; Mastroianni, Cm; Montella, F; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Santoro, Mm";s:9:"metadata7";s:20:"10.1128/JCM.00656-17";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:20;a:14:{s:9:"citazione";s:240:"Armenia, D., Di Carlo, D., Maffongelli, G., Borghi, V., Alteri, C., Forbici, F., et al. (2017). Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens. HIV MEDICINE [10.1111/hiv.12388].";s:4:"data";s:7:"2017-01";s:2:"id";s:20:"PUBBLICAZIONE_290345";s:6:"handle";s:11:"2108/162521";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:109:"Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens";s:9:"metadata6";s:261:"Armenia, D; Di Carlo, D; Maffongelli, G; Borghi, V; Alteri, C; Forbici, F; Bertoli, A; Gori, C; Giuliani, M; Nicastri, E; Zaccarelli, M; Pinnetti, C; Cicalini, S; D'Offizi, G; Ceccherini-Silberstein, F; Mussini, C; Antinori, A; Andreoni, M; Perno, C; Santoro, M";s:9:"metadata7";s:17:"10.1111/hiv.12388";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:21;a:14:{s:9:"citazione";s:299:"Fabeni, L., Alteri, C., Di Carlo, D., Orchi, N., Carioti, L., Bertoli, A., et al. (2017). Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(10), 2837-2845 [10.1093/jac/dkx231].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_327237";s:6:"handle";s:11:"2108/194918";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:129:"Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14";s:9:"metadata6";s:817:"Fabeni, L; Alteri, C; Di Carlo, D; Orchi, N; Carioti, L; Bertoli, A; Gori, C; Forbici, F; Continenza, F; Maffongelli, G; Pinnetti, C; Vergori, A; Mondi, A; Ammassari, A; Borghi, V; Giuliani, M; De Carli, G; Pittalis, S; Grisetti, S; Pennica, A; Mastroianni, C; Montella, F; Cristaudo, A; Mussini, C; Girardi, E; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M; Capobianchi, M; Navarra, A; Palummieria, ; Abbate, I; D'Arrigo, R; Fusco, F; Mariano, A; Nicastri, E; Nurra, G; Puro, V; Sampaolesi, A; Sciarrone, M; Scognamiglio, P; Selleri, M; Sias, C; Zaccarelli, M; Di Carlo, A; Giuliani, M; Vullo, V; Falciano, M; Errigo, F; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Buonomini, Ar; Cerva, C; Mastroianni, C; Lichtner, M; Mercurio, V; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S";s:9:"metadata7";s:18:"10.1093/jac/dkx231";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:22;a:14:{s:9:"citazione";s:312:"Rhee, S.-., Varghese, V., Holmes, S.P., Van Zyl, G.U., Steegen, K., Boyd, M.A., et al. (2017). Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. EBIOMEDICINE, 18, 225-235 [10.1016/j.ebiom.2017.03.024].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_385088";s:6:"handle";s:11:"2108/243384";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:159:"Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration";s:9:"metadata6";s:535:"Rhee, S-; Varghese, V; Holmes, SP; Van Zyl, GU; Steegen, K; Boyd, MA; Cooper, DA; Nsanzimana, S; Saravanan, S; Charpentier, C; de Oliveira, T; Etiebet, M-A; Garcia, F; Goedhals, D; Gomes, P; Gunthard, HF; Hamers, RL; Hoffmann, CJ; Hunt, G; Jiamsakul, A; Kaleebu, P; Kanki, P; Kantor, R; Kerschberger, B; Marconi, VC; D'amour Ndahimana, J; Ndembi, N; Ngo-Giang-Huong, N; Rokx, C; Santoro, M; Schapiro, JM; Schmidt, D; Seu, L; Sigaloff, KCE; Sirivichayakul, S; Skhosana, L; Sunpath, H; Tang, M; Yang, C; Carmona, S; Gupta, RK; Shafer, RW";s:9:"metadata7";s:27:"10.1016/j.ebiom.2017.03.024";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:23;a:14:{s:9:"citazione";s:319:"Nanfack, A.J., Takou, D., Fokam, J., Salpini, R., Santoro, M.M., Cappelli, G., et al. (2016). HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design. CURRENT HIV RESEARCH, 15(1), 66-73 [10.2174/1570162X14666161230105417].";s:4:"data";s:10:"2016-12-29";s:2:"id";s:20:"PUBBLICAZIONE_302373";s:6:"handle";s:11:"2108/173533";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:152:"HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design";s:9:"metadata6";s:190:"Nanfack, AJ; Takou, D; Fokam, J; Salpini, R; Santoro, MM; Cappelli, G; Baane, M; Tetang, Sm; Eberle, J; Gürtler, L; Ceccherini-Silberstein, F; Torimiro, JN; Colizzi, V; Perno, C; Ndjolo, A";s:9:"metadata7";s:33:"10.2174/1570162X14666161230105417";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:24;a:14:{s:9:"citazione";s:356:"Armenia, D., Di Carlo, D., Calcagno, A., Vendemiati, G., Forbici, F., Bertoli, A., et al. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, dkw512 [10.1093/jac/dkw512].";s:4:"data";s:10:"2016-12-20";s:2:"id";s:20:"PUBBLICAZIONE_302355";s:6:"handle";s:11:"2108/173068";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:189:"Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen";s:9:"metadata6";s:306:"Armenia, D; Di Carlo, D; Calcagno, A; Vendemiati, G; Forbici, F; Bertoli, A; Berno, G; Carta, S; Continenza, F; Fedele, V; Bellagamba, R; Cicalini, S; Ammassari, A; Libertone, R; Zaccarelli, M; Ghisetti, V; Andreoni, M; Ceccherini-Silberstein, F; Bonora, S; Di Perri, G; Antinori, A; Perno, Cf; Santoro, MM";s:9:"metadata7";s:18:"10.1093/jac/dkw512";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:25;a:14:{s:9:"citazione";s:337:"Alteri, C., Surdo, M., Di Maio, V., Di Santo, F., Costa, G., Parrotta, L., et al. (2016). The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 7, 1-7 [10.1016/j.jgar.2016.06.005].";s:4:"data";s:7:"2016-12";s:2:"id";s:20:"PUBBLICAZIONE_290338";s:6:"handle";s:11:"2108/162513";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:165:"The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro";s:9:"metadata6";s:356:"Alteri, C; Surdo, M; Di Maio, V; Di Santo, F; Costa, G; Parrotta, L; Romeo, I; Gori, C; Santoro, M; Fedele, V; Carta, S; Continenza, F; Pinnetti, C; Bellagamba, R; Liuzzi, G; Orchi, N; Latini, A; Bertoli, A; Girardi, E; Alcaro, S; Giuliani, M; Petrosillo, N; Andreoni, M; Antinori, A; Monforte, A; Ceccherini-Silberstein, F; Artese, A; Perno, C; Svicher, V";s:9:"metadata7";s:26:"10.1016/j.jgar.2016.06.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:26;a:14:{s:9:"citazione";s:335:"De Luca, A., Flandre, P., Dunn, D., Zazzi, M., Wensing, A., Santoro, M.m., et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(5), 1352-1360 [10.1093/jac/dkv465].";s:4:"data";s:7:"2016-05";s:2:"id";s:20:"PUBBLICAZIONE_280985";s:6:"handle";s:11:"2108/155473";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:166:"Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen";s:9:"metadata6";s:1903:"De Luca, A; Flandre, P; Dunn, D; Zazzi, M; Wensing, A; Santoro, Mm; Gunthard, Hf; Wittkop, L; Kordossis, T; Garcia, F; Castagna, A; Cozzi-Lepri, A; Churchill, D; De Wit, S; Brockmeyer, Nh; Imaz, A; Mussini, C; Obel, N; Perno, Cf; Roca, B; Reiss, P; Schulter, E; Torti, C; van Sighem, A; Zangerle, R; Descamps, D; Mocroft, A; Kirk, O; Sabin, C; De Wit, S; Casabona, J; Miro, Jm; Touloumi, G; Garrido, M; Teira, R; Wit, F; Warszawski, J; Meyer, L; Dabis, F; Krause, Mm; Ghosn, J; Leport, C; Prins, M; Bucher, H; Gibb, D; Fatkenheuer, G; del Amo, J; Thorne, C; Stephan, C; Perez-Hoyos, S; Hamouda, O; Bartmeyer, B; Chkhartishvili, N; Noguera-Julian, A; Antinori, A; d'Arminio Monforte, A; Prieto, L; Conejo, Pr; Soriano-Arandes, A; Battegay, M; Kouyos, R; Tookey, P; Konopnick, D; Goetghebuer, T; Sonnerborg, A; Haerry, D; de Wit, S; Costagliola, D; Raben, D; Chene, G; Ceccherini-Silberstein, F; Gunthard, H; Judd, A; Barger, D; Schwimmer, C; Termote, M; Campbell, M; Frederiksen, Cm; Friis-Moller, N; Kjaer, J; Brandt, Rs; Berenguer, J; Bohlius, J; Bouteloup, V; Davies, M-; Dorrucci, M; Egger, M; Furrer, H; Guiguet, M; Grabar, S; Lambotte, O; Leroy, V; Lodi, S; Matheron, S; Monge, S; Nakagawa, F; Paredes, R; Phillips, A; Puoti, M; Schomaker, M; Smit, C; Sterne, J; Thiebaut, R; van der Valk, M; Wyss, N; Aubert, V; Battegay, M; Bernasconi, E; Boni, J; Burton-Jeangros, C; Calmy, A; Cavassini, M; Dollenmaier, G; Egger, M; Elzi, L; Fehr, J; Fellay, J; Furrer, H; Fux, Ca; Gorgievski, M; Gunthard, H; Haerry, D; Hasse, B; Hirsch, Hh; Hoffmann, M; Hosli, I; Kahlert, C; Kaiser, L; Keiser, O; Klimkait, T; Kouyos, R; Kovari, H; Ledergerber, B; Martinetti, G; Martinez de Tejada, B; Metzner, K; Muller, N; Nadal, D; Nicca, D; Pantaleo, G; Rauch, A; Regenass, S; Rickenbach, M; Rudin, C; Schoni-Affolter, F; Schmid, P; Schupbach, J; Speck, R; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S";s:9:"metadata7";s:18:"10.1093/jac/dkv465";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:27;a:14:{s:9:"citazione";s:331:"Gregson, J., Tang, M., Ndembi, N., Hamers, R.L., Marconi, V.C., Brooks, K., et al. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study. THE LANCET INFECTIOUS DISEASES, 16(5), 565-575 [10.1016/S1473-3099(15)00536-8].";s:4:"data";s:7:"2016-05";s:2:"id";s:20:"PUBBLICAZIONE_385096";s:6:"handle";s:11:"2108/243388";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:159:"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study";s:9:"metadata6";s:880:"Gregson, J; Tang, M; Ndembi, N; Hamers, RL; Marconi, VC; Brooks, K; Theys, K; Arruda, M; Garcia, F; Monge, S; Kanki, PJ; Kumarasamy, N; Kerschberger, B; Mor, O; Charpentier, C; Todesco, E; Rokx, C; Gras, L; Halvas, EK; Sunpath, H; Carlo, DD; Antinori, A; Andreoni, M; Latini, A; Mussini, C; Aghokeng, A; Sonnerborg, A; Neogi, U; Fessel, WJ; Agolory, S; Yang, C; Blanco, JL; Juma, JM; Smit, E; Schmidt, D; Watera, C; Asio, J; Kirungi, W; Tostevin, A; Clumeck, N; Goedhals, D; Bester, PA; Sabin, C; Mukui, I; Santoro, M; Perno, CF; Hunt, G; Morris, L; Pillay, D; Schulter, E; Reyes-Teran, G; Romero, K; Avila-Rios, S; Sirivichayakul, S; Ruxrungtham, K; Mekprasan, S; Dunn, D; Kaleebu, P; Raizes, E; Kantor, R; Gupta, RK; Rhee, S-; Shafer, RW; de Wit, TFR; Diero, L; Camacho, R; Gunthard, HF; Hoffmann, CJ; Di Carlo, D; El-Hay, T; van Vuuren, C; de Oliveira, T; Murakami-Ogasawara, A";s:9:"metadata7";s:29:"10.1016/S1473-3099(15)00536-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:28;a:14:{s:9:"citazione";s:128:"Santoro, M.M., & Perno, C.F. (2016). Clinical relevance of genotypic resistance testing today. NEW MICROBIOLOGICA, 39(2), 91-92.";s:4:"data";s:7:"2016-04";s:2:"id";s:20:"PUBBLICAZIONE_281026";s:6:"handle";s:11:"2108/155507";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:56:"Clinical relevance of genotypic resistance testing today";s:9:"metadata6";s:22:"Santoro, MM; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:29;a:14:{s:9:"citazione";s:343:"Di Maio, V., Cento, V., Di Paolo, D., Aragri, M., De Leonardis, F., Tontodonati, M., et al. (2016). HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(3), 739-750 [10.1093/jac/dkv403].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253738";s:6:"handle";s:11:"2108/133470";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:166:"HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels";s:9:"metadata6";s:2229:"Di Maio, V; Cento, V; Di Paolo, D; Aragri, M; De Leonardis, F; Tontodonati, M; Micheli, V; Bellocchi, M; Antonucci, F; Bertoli, A; Lenci, I; Milana, M; Gianserra, L; Melis, M; Di Biagio, A; Sarrecchia, C; Sarmati, L; Landonio, S; Francioso, S; Lambiase, L; Nicolini, L; Marenco, S; Nosotti, L; Giannelli, V; Siciliano, M; Romagnoli, D; Pellicelli, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, M; Taliani, G; Mastroianni, C; Vespasiani Gentilucci, U; Romano, M; Morisco, F; Gasbarrini, A; Vullo, V; Bruno, S; Baiguera, C; Pasquazzi, C; Tisone, G; Picciotto, A; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, CF; Ceccherini Silberstein, F; Mariani, R; Paoloni, M; Iapadre, N; Grimaldi, A; Menzaghi, B; Quirino, T; Vecchiet, J; Bruzzone, B; De Maria, A; Di Biagio, A; Marenco, S; Nicolini, L; Picciotto, A; Viscoli, C; Casinelli, K; Monache, M; Lichtner, M; Mastroianni, C; Aghemo, A; Bruno, S; Cerrone, M; Colombo, M; Monforte, A; Danieli, E; Donato, F; Gubertini, G; Landonio, S; Magni, C; Mancon, A; Micheli, V; Monico, S; Niero, F; Puoti, M; Rizzardini, G; Russo, M; Alfieri, R; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Romagnoli, D; Brancaccio, G; Caporaso, N; Gaeta, G; Lembo, V; Morisco, F; Calvaruso, V; Craxì, A; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Palitti, V; Parruti, G; Pieri, A; Polilli, E; Tontodonati, M; Andreoni, M; Angelico, M; Antenucci, F; Antonucci, F; Aragri, M; Armenia, D; Baiocchi, L; Bellocchi, M; Biliotti, E; Biolato, M; Carioti, L; Cento, V; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, V; Di Paolo, D; Francioso, S; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Gianserra, L; Grieco, A; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Malagnino, V; Manuelli, M; Merli, M; Miglioresi, L; Milana, M; Nosotti, L; Palazzo, D; Pasquazzi, C; Pellicelli, A; Romano, M; Santopaolo, F; Santoro, M; Sarmati, L; Sarrecchia, C; Sforza, D; Siciliano, M; Sorbo, M; Spaziante, M; Svicher, V; Taliani, G; Teti, E; Tisone, G; Vespasiani Gentilucci, U; Vullo, V; Mangia, A; Babudieri, S; Maida, I; Melis, M; Mura, M; Falconi, L; Di Giammartino, D; Tarquini, P";s:9:"metadata7";s:18:"10.1093/jac/dkv403";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:30;a:14:{s:9:"citazione";s:369:"Fokam, J., Takou, D., Santoro, M., Akonie, H., Kouanfack, C., Ceccherini Silberstein, F., et al. (2016). Short communication: Population-based surveillance of HIV-1 drug resistance in cameroonian adults initiating antiretroviral therapy according to the world health organization guidelines. AIDS RESEARCH AND HUMAN RETROVIRUSES, 32(4), 329-333 [10.1089/AID.2015.0065].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253985";s:6:"handle";s:11:"2108/133873";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:185:"Short communication: Population-based surveillance of HIV-1 drug resistance in cameroonian adults initiating antiretroviral therapy according to the world health organization guidelines";s:9:"metadata6";s:116:"Fokam, J; Takou, D; Santoro, M; Akonie, H; Kouanfack, C; Ceccherini Silberstein, F; Colizzi, V; Perno, CF; Ndjolo, A";s:9:"metadata7";s:21:"10.1089/AID.2015.0065";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:31;a:14:{s:9:"citazione";s:277:"Maffongelli, G., Alterib, C., Gentilotti, E., Bertoli, A., Ricciardi, A., Malagnino, V., et al. (2016). Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy. AIDS [10.1097/QAD.0000000000000977].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253986";s:6:"handle";s:11:"2108/133866";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:135:"Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy";s:9:"metadata6";s:151:"Maffongelli, G; Alterib, C; Gentilotti, E; Bertoli, A; Ricciardi, A; Malagnino, V; Svicher, V; Santoro, Mm; Dori, L; Perno, Cf; Andreoni, M; Sarmati, L";s:9:"metadata7";s:28:"10.1097/QAD.0000000000000977";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:32;a:14:{s:9:"citazione";s:252:"Salpini, R., Fokam, J., Ceccarelli, L., Santoro, M., Nanfack, A., Sosso, S., et al. (2016). High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. CURRENT HIV RESEARCH, 14(2), 165-171 [10.2174/1570162X13666150930114742].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253989";s:6:"handle";s:11:"2108/133684";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:85:"High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians";s:9:"metadata6";s:159:"Salpini, R; Fokam, J; Ceccarelli, L; Santoro, M; Nanfack, A; Sosso, S; Kowo, M; Cento, V; Torimiro, J; Sarmati, L; Andreoni, M; Colizzi, V; Perno, Cf; Njoya, O";s:9:"metadata7";s:33:"10.2174/1570162X13666150930114742";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:33;a:14:{s:9:"citazione";s:335:"Zaccarelli, M., Santoro, M.m., Armenia, D., Borghi, V., Gennari, W., Gori, C., et al. (2016). Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. JOURNAL OF CLINICAL VIROLOGY, 82, 94-100 [10.1016/j.jcv.2016.07.007].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_290346";s:6:"handle";s:11:"2108/162527";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:170:"Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA";s:9:"metadata6";s:240:"Zaccarelli, M; Santoro, Mm; Armenia, D; Borghi, V; Gennari, W; Gori, C; Forbici, F; Bertoli, A; Fabeni, L; Giannetti, A; Cicalini, S; Bellagamba, R; Andreoni, M; Mastroianni, Cm; Mussini, C; Ceccherini-Silberstein, F; Perno, CF; Antinori, A";s:9:"metadata7";s:25:"10.1016/j.jcv.2016.07.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:34;a:14:{s:9:"citazione";s:232:"Andreoni, M., Marcotullio, S., Puro, V., De Carli, G., Tambussi, G., Nozza, S., et al. (2015). An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. NEW MICROBIOLOGICA, 38(4), 443-490.";s:4:"data";s:7:"2015-11";s:2:"id";s:20:"PUBBLICAZIONE_253990";s:6:"handle";s:11:"2108/133863";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:100:"An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project";s:9:"metadata6";s:411:"Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, Mm; Clementi, M; Perno, Cf; d'Arminio Monforte, A; Maggiolo, F; Castagna, A; De Luca, A; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:35;a:14:{s:9:"citazione";s:277:"Fabeni, L., Berno, G., Svicher, V., Ceccherini-Silberstein, F., Gori, C., Bertoli, A., et al. (2015). Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia. JOURNAL OF CLINICAL MICROBIOLOGY, 53(9), 2935-2941 [10.1128/JCM.00893-15].";s:4:"data";s:7:"2015-07";s:2:"id";s:20:"PUBBLICAZIONE_253960";s:6:"handle";s:11:"2108/133648";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:99:"Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia";s:9:"metadata6";s:223:"Fabeni, L; Berno, G; Svicher, V; Ceccherini-Silberstein, F; Gori, C; Bertoli, A; Mussini, C; Lichtner, M; Zaccarelli, M; Ammassari, A; Pinnetti, C; Cicalini, S; Mastroianni, C; Andreoni, M; Antinori, A; Perno, C; Santoro, M";s:9:"metadata7";s:20:"10.1128/JCM.00893-15";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:36;a:14:{s:9:"citazione";s:343:"Vingerhoets, J., Calvez, V., Flandre, P., Marcelin, A.-., Ceccherini Silberstein, F., Perno, C.F., et al. (2015). Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: An observational study using pooled European cohort data. HIV MEDICINE, 16(5), 297-306 [10.1111/hiv.12218].";s:4:"data";s:10:"2015-01-14";s:2:"id";s:20:"PUBBLICAZIONE_231203";s:6:"handle";s:11:"2108/113124";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:178:"Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: An observational study using pooled European cohort data";s:9:"metadata6";s:317:"Vingerhoets, J; Calvez, V; Flandre, P; Marcelin, A-; Ceccherini Silberstein, F; Perno, CF; Santoro, M; Bateson, R; Nelson, M; Cozzi Lepri, A; Grarup, J; Lundgren, J; Incardona, F; Kaiser, R; Sonnerborg, A; Clotet, B; Paredes, R; Gunthard, H; Ledergerber, B; Hoogstoel, A; Nijs, S; Tambuyzer, L; Lavreys, L; Opsomer, M";s:9:"metadata7";s:17:"10.1111/hiv.12218";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:37;a:14:{s:9:"citazione";s:333:"Armenia, D., Fabeni, L., Alteri, C., Di Pinto, D., Di Carlo, D., Bertoli, A., et al. (2015). HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 70(6), 1865-1873 [10.1093/jac/dkv029].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_253968";s:6:"handle";s:11:"2108/133655";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia";s:9:"metadata6";s:308:"Armenia, D; Fabeni, L; Alteri, C; Di Pinto, D; Di Carlo, D; Bertoli, A; Gori, C; Carta, S; Fedele, V; Forbici, F; D'Arrigo, R; Svicher, V; Berno, G; Pizzi, D; Nicastri, E; Sarmati, L; Pinnetti, C; Ammassari, A; D'Offizi, G; Latini, A; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M";s:9:"metadata7";s:18:"10.1093/jac/dkv029";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:38;a:14:{s:9:"citazione";s:291:"Fabeni, L., Alteri, C., Orchi, N., Gori, C., Bertoli, A., Forbici, F., et al. (2015). Recent transmission clustering of HIV-1 C and CRF17-BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy. PLOS ONE, 10(8), e0135325 [10.1371/journal.pone.0135325].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_254005";s:6:"handle";s:11:"2108/133892";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:146:"Recent transmission clustering of HIV-1 C and CRF17-BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy";s:9:"metadata6";s:258:"Fabeni, L; Alteri, C; Orchi, N; Gori, C; Bertoli, A; Forbici, F; Montella, F; Pennica, A; De Carli, G; Giuliani, M; Continenza, F; Pinnetti, C; Nicastri, E; Ceccherini-Silberstein, F; Mastroianni, C; Girardi, E; Andreoni, M; Antinori, A; Santoro, M; Perno, C";s:9:"metadata7";s:28:"10.1371/journal.pone.0135325";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:39;a:14:{s:9:"citazione";s:368:"Blanco, J.l., Montaner, J., Marconi, V.c., Santoro, M.m., Campos-Loza, A.e., Shafer, R.w., et al. (2014). Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy. AIDS, 28(17), 2531-2539 [10.1097/QAD.0000000000000424].";s:4:"data";s:10:"2014-11-13";s:2:"id";s:20:"PUBBLICAZIONE_231199";s:6:"handle";s:11:"2108/113120";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:205:"Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy";s:9:"metadata6";s:176:"Blanco, Jl; Montaner, Jsg; Marconi, Vc; Santoro, Mm; Campos-Loza, Ae; Shafer, Rw; Miller, Md; Paredes, R; Harrigan, R; Nguyen, Ml; Perno, Cf; Gonzalez-Hernandez, La; Gatell, Jm";s:9:"metadata7";s:28:"10.1097/QAD.0000000000000424";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:40;a:14:{s:9:"citazione";s:304:"Mirabelli, C., Surdo, M., Van Hemert, F., Lian, Z., Salpini, R., Cento, V., et al. (2014). Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. JOURNAL OF INFECTION [10.1016/j.jinf.2014.10.015].";s:4:"data";s:10:"2014-11-06";s:2:"id";s:20:"PUBBLICAZIONE_214490";s:6:"handle";s:11:"2108/113050";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection";s:9:"metadata6";s:401:"Mirabelli, C; Surdo, M; Van Hemert, F; Lian, Z; Salpini, R; Cento, V; Cortese, M; Aragri, M; Pollicita, M; Alteri, C; Bertoli, A; Berkhout, B; Micheli, V; Gubertini, G; Santoro, M; Romano, S; Visca, M; Bernassola, M; Longo, R; De Sanctis, G; Trimoulet, P; Fleury, H; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; Zhang, J; Andreoni, M; Angelico, M; Verheyen, J; Perno, C; Svicher, V";s:9:"metadata7";s:26:"10.1016/j.jinf.2014.10.015";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:41;a:14:{s:9:"citazione";s:282:"Armenia, D., Soulie, C., Di Carlo, D., Fabeni, L., Gori, C., Forbici, F., et al. (2014). A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. PLOS ONE, 9(8) [10.1371/journal.pone.0105853].";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_213108";s:6:"handle";s:11:"2108/100778";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.";s:9:"metadata6";s:268:"Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, AG; Calvez, V; Antinori A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:28:"10.1371/journal.pone.0105853";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:42;a:14:{s:9:"citazione";s:287:"Svicher, V., Alteri, C., Santoro, M., Ceccherini-Silberstein, F., Marcelin, A., Calvez, V., et al. (2014). The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: Evidences from literature. JOURNAL OF INFECTION [10.1016/j.jinf.2014.05.001].";s:4:"data";s:10:"2014-05-15";s:2:"id";s:20:"PUBBLICAZIONE_185038";s:6:"handle";s:10:"2108/89696";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:128:"The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: Evidences from literature";s:9:"metadata6";s:94:"Svicher, V; Alteri, C; Santoro, M; Ceccherini-Silberstein, F; Marcelin, A; Calvez, V; Perno, C";s:9:"metadata7";s:26:"10.1016/j.jinf.2014.05.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:43;a:14:{s:9:"citazione";s:266:"Santoro, M., Fabeni, L., Armenia, D., Alteri, C., Di Pinto, D., Forbici, F., et al. (2014). Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. CLINICAL INFECTIOUS DISEASES, 58(8), 1156-1164 [10.1093/cid/ciu020].";s:4:"data";s:7:"2014-04";s:2:"id";s:20:"PUBBLICAZIONE_185030";s:6:"handle";s:10:"2108/89703";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:104:"Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels";s:9:"metadata6";s:312:"Santoro, M; Fabeni, L; Armenia, D; Alteri, C; Di Pinto, D; Forbici, F; Bertoli, A; Di Carlo, D; Gori, C; Carta, S; Fedele, V; D'Arrigo, R; Berno, G; Ammassari, A; Pinnetti, C; Nicastri, E; Latini, A; Tommasi, C; Boumis, E; Petrosillo, N; D'Offizi, G; Andreoni, M; Ceccherini Silberstein, F; Antinori, A; Perno, C";s:9:"metadata7";s:18:"10.1093/cid/ciu020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:44;a:14:{s:9:"citazione";s:316:"Santoro, M., Sabin, C., Forbici, F., Bansi, L., Dunn, D., Fearnhill, E., et al. (2013). Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues. HIV MEDICINE, 841-845.";s:4:"data";s:10:"2013-05-13";s:2:"id";s:20:"PUBBLICAZIONE_156778";s:6:"handle";s:10:"2108/74547";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:204:"Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues";s:9:"metadata6";s:227:"Santoro, M; Sabin, C; Forbici, F; Bansi, L; Dunn, D; Fearnhill, E; Boumis, E; Nicastri, E; Antinori, A; Palamara, G; Callegaro, A; Francisci, D; Zoncada, A; Maggiolo, F; Zazzi, M; Perno, C; Ceccherini-Silberstein, F; Mussini, C";s:9:"metadata7";s:17:"10.1111/hiv.12044";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:45;a:14:{s:9:"citazione";s:350:"Alteri, C., Artese, A., Beheydt, G., Santoro, M., Costa, G., Parrotta, L., et al. (2013). Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 68(10), 2205-2209 [10.1093/jac/dkt173].";s:4:"data";s:7:"2013-05";s:2:"id";s:20:"PUBBLICAZIONE_254428";s:6:"handle";s:11:"2108/134050";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:180:"Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen";s:9:"metadata6";s:230:"Alteri, C; Artese, A; Beheydt, G; Santoro, M; Costa, G; Parrotta, L; Bertoli, A; Gori, C; Orchi, N; Girardi, E; Antinori, A; Alcaro, S; d'Arminio Monforte, A; Theys, K; Vandamme, A; CECCHERINI SILBERSTEIN, F; Svicher, V; Perno, Cf";s:9:"metadata7";s:18:"10.1093/jac/dkt173";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:46;a:14:{s:9:"citazione";s:230:"Santoro, M., Armenia, D., Alteri, C., Flandre, P., Calcagno, A., Santoro, M., et al. (2013). Impact of pre-therapy viral load on virological response to modern first-line HAART. ANTIVIRAL THERAPY, 18(7), 867-876 [10.3851/IMP2531].";s:4:"data";s:10:"2013-01-23";s:2:"id";s:20:"PUBBLICAZIONE_156781";s:6:"handle";s:10:"2108/74567";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:83:"Impact of pre-therapy viral load on virological response to modern first-line HAART";s:9:"metadata6";s:365:"Santoro, M; Armenia, D; Alteri, C; Flandre, P; Calcagno, A; Santoro, M; Gori, C; Fabeni, L; Bellagamba, R; Borghi, V; Forbici, F; Latini, A; Palamara, G; Libertone, R; Tozzi, V; Boumis, E; Tommasi, C; Pinnetti, C; Ammassari, A; Nicastri, E; Buonomini, A; Svicher, V; Andreoni, M; Narciso, P; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Di Perri, G; Perno, C";s:9:"metadata7";s:15:"10.3851/IMP2531";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:47;a:14:{s:9:"citazione";s:253:"Giuliani, M., Santoro, M., Lo Presti, A., Cella, E., Scognamiglio, P., Lai, A., et al. (2013). Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study. BIOMED RESEARCH INTERNATIONAL, 2013, 810617-810617.";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_185040";s:6:"handle";s:10:"2108/89713";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:105:"Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study";s:9:"metadata6";s:164:"Giuliani, M; Santoro, M; Lo Presti, A; Cella, E; Scognamiglio, P; Lai, A; Latini, A; Fabeni, L; Gori, C; Pinnetti, C; Girardi, E; Perno, C; Zehender, G; Ciccozzi, M";s:9:"metadata7";s:19:"10.1155/2013/810617";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:48;a:14:{s:9:"citazione";s:125:"Santoro, M., & Perno, C. (2013). HIV-1 Genetic Variability and Clinical Implications. ISRN MICROBIOLOGY, 2013, 481314-481314.";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_158898";s:6:"handle";s:10:"2108/75667";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:51:"HIV-1 Genetic Variability and Clinical Implications";s:9:"metadata6";s:20:"Santoro, M; Perno, C";s:9:"metadata7";s:19:"10.1155/2013/481314";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:49;a:14:{s:9:"citazione";s:257:"Svicher, V., Cento, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2013). The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLOS ONE, 8(1).";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_156780";s:6:"handle";s:10:"2108/74568";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:151:"The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing";s:9:"metadata6";s:256:"Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; Ceccherini Silberstein, F; Capobianchi, M; Perno, CF";s:9:"metadata7";s:28:"10.1371/journal.pone.0053603";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:50;a:14:{s:9:"citazione";s:174:"Ciccozzi, M., Santoro, M., Giovanetti, M., Andrissi, L., Bertoli, A., & Ciotti, M. (2012). HIV-1 non-B subtypes in Italy: a growing trend. NEW MICROBIOLOGICA, 35(4), 377-386.";s:4:"data";s:7:"2012-10";s:2:"id";s:20:"PUBBLICAZIONE_247882";s:6:"handle";s:11:"2108/129016";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:46:"HIV-1 non-B subtypes in Italy: a growing trend";s:9:"metadata6";s:74:"Ciccozzi, M; Santoro, M; Giovanetti, M; Andrissi, L; Bertoli, A; Ciotti, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:51;a:14:{s:9:"citazione";s:281:"Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2012). The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. CLINICAL MICROBIOLOGY AND INFECTION, 18(8) [10.1111/j.1469-0691.2012.03905.x].";s:4:"data";s:10:"2012-08-03";s:2:"id";s:20:"PUBBLICAZIONE_139056";s:6:"handle";s:10:"2108/68004";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:112:"The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients";s:9:"metadata6";s:235:"Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Dori, L; Surdo, M; Balestra, E; Palamara, G; Girardi, E; Angarano, G; Andreoni, M; Narciso, P; Antinori, A; Ceccherini Silberstein, F; Perno, C";s:9:"metadata7";s:32:"10.1111/j.1469-0691.2012.03905.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:52;a:14:{s:9:"citazione";s:280:"Ceccarelli, L., Salpini, R., Moudourou, S., Cento, V., Santoro, M., Fokam, J., et al. (2012). Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. JOURNAL OF MEDICAL VIROLOGY, 84(5), 721-727 [10.1002/jmv.23244].";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138901";s:6:"handle";s:10:"2108/67928";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon";s:9:"metadata6";s:175:"Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, C; Colizzi, V; Cappelli, G";s:9:"metadata7";s:17:"10.1002/jmv.23244";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:53;a:14:{s:9:"citazione";s:300:"Santoro, M.M., Alteri, C., Ronga, L., Flandre, P., Fabeni, L., Mercurio, F., et al. (2012). Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 28(10), 1285-1293 [10.1089/aid.2011.0142].";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_148048";s:6:"handle";s:10:"2108/71248";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:126:"Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy";s:9:"metadata6";s:285:"Santoro, MM; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco-Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; Ceccherini-Silberstein, F; Perno, CF";s:9:"metadata7";s:21:"10.1089/aid.2011.0142";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:54;a:14:{s:9:"citazione";s:345:"Alcaro, S., Alteri, C., Artese, A., Ceccherini-Silberstein, F., Costa, G., Ortuso, F., et al. (2011). Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine. CHEMMEDCHEM, 6(12), 2203-2213 [10.1002/cmdc.201100362].";s:4:"data";s:10:"2011-12-09";s:2:"id";s:19:"PUBBLICAZIONE_81007";s:6:"handle";s:10:"2108/50407";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:186:"Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine";s:9:"metadata6";s:223:"Alcaro, S; Alteri, C; Artese, A; Ceccherini-Silberstein, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, C; Sing, T; Svicher, V";s:9:"metadata7";s:22:"10.1002/cmdc.201100362";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:55;a:14:{s:9:"citazione";s:328:"Alteri, C., Santoro, M.M., Abbate, I., Rozera, G., Bruselles, A., Bartolini, B., et al. (2011). 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkr354].";s:4:"data";s:10:"2011-09-02";s:2:"id";s:19:"PUBBLICAZIONE_62702";s:6:"handle";s:10:"2108/18064";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:171:"'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing";s:9:"metadata6";s:230:"Alteri, C; Santoro, MM; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; Ceccherini-Silberstein, F; Capobianchi, MR; Perno, CF";s:9:"metadata7";s:18:"10.1093/jac/dkr354";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:56;a:14:{s:9:"citazione";s:333:"Alteri, C., Santoro, M.M., Abbate, I., Rozera, G., Bruselles, A., Bartolini, B., et al. (2011). 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [doi: 10.1093/jac/dkr354].";s:4:"data";s:7:"2011-09";s:2:"id";s:19:"PUBBLICAZIONE_66434";s:6:"handle";s:10:"2108/19420";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:171:"'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing";s:9:"metadata6";s:231:"Alteri, C; Santoro, MM; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C, Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; Ceccherini-Silberstein, F; Capobianchi, MR; Perno, CF.";s:9:"metadata7";s:23:"doi: 10.1093/jac/dkr354";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:57;a:14:{s:9:"citazione";s:264:"Fokam, J., Salpini, R., Santoro, M.M., Cento, V., Perno, C., Colizzi, V., et al. (2011). Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon. THE PEDIATRIC INFECTIOUS DISEASE JOURNAL [10.1097/INF.0b013e31822db54c].";s:4:"data";s:10:"2011-08-03";s:2:"id";s:19:"PUBBLICAZIONE_58915";s:6:"handle";s:10:"2108/18068";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:101:"Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon";s:9:"metadata6";s:161:"Fokam, J; Salpini, R; Santoro, MM; Cento, V; Perno, C; Colizzi, V; Ndumbe, PM; Fokunang Ntungen, C; Ndiang Tetang, SM; Nanfack, AJ; Takou Komego, DA; Cappelli, G";s:9:"metadata7";s:28:"10.1097/INF.0b013e31822db54c";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:58;a:14:{s:9:"citazione";s:224:"Ciccozzi, M., Vujošević, D., Lo Presti, A., Mugoša, B., Vratnica, Z., Lai, A., et al. (2011). Genetic diversity of HIV type 1 in Montenegro. AIDS RESEARCH AND HUMAN RETROVIRUSES, 27(8), 921-924 [10.1089/AID.2010.0323].";s:4:"data";s:7:"2011-08";s:2:"id";s:20:"PUBBLICAZIONE_247883";s:6:"handle";s:11:"2108/129013";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:45:"Genetic diversity of HIV type 1 in Montenegro";s:9:"metadata6";s:196:"Ciccozzi, M; Vujošević, D; Lo Presti, A; Mugoša, B; Vratnica, Z; Lai, A; Laušević, D; Drašković, N; Marjanovic, A; Cella, E; Santoro, Mm; Alteri, C; Fabeni, L; Ciotti, M; Zehender, G";s:9:"metadata7";s:21:"10.1089/AID.2010.0323";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:59;a:14:{s:9:"citazione";s:226:"Véras, N., Santoro, M.M., Gray, R.R., Tatem, A.J., Presti, A.L., Olearo, F., et al. (2011). Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy. AIDS RESEARCH AND HUMAN RETROVIRUSES.";s:4:"data";s:10:"2011-05-06";s:2:"id";s:19:"PUBBLICAZIONE_35808";s:6:"handle";s:10:"2108/18800";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:94:"Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy";s:9:"metadata6";s:213:"Véras, NMC; Santoro, MM; Gray, RR; Tatem, AJ; Presti, AL; Olearo, F; Cappelli, G; Colizzi, V; Takou, D; Torimiro, J; Russo, G; Callegaro, A; Salpini, R; D'Arrigo, R; Perno, C; Goodenow, MM; Ciccozzi, M; Salemi, M";s:9:"metadata7";s:21:"10.1089/AID.2010.0333";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:60;a:14:{s:9:"citazione";s:264:"Fokam, J., Salpini, R., Santoro, M.M., Cento, V., D'Arrigo, R., Gori, C., et al. (2011). Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. ARCHIVES OF VIROLOGY, 156(7), 1235-1243.";s:4:"data";s:10:"2011-04-05";s:2:"id";s:19:"PUBBLICAZIONE_35799";s:6:"handle";s:10:"2108/19208";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:133:"Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon";s:9:"metadata6";s:133:"Fokam, J; Salpini, R; Santoro, MM; Cento, V; D'Arrigo, R; Gori, C; Perno, CF; Colizzi, V; Nanfack, A; Gwom, LC; Cappelli, G; Takou, D";s:9:"metadata7";s:25:"10.1007/s00705-011-0982-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:61;a:14:{s:9:"citazione";s:397:"Ceccherini-Silberstein, F., Surdo, M., Alteri, C., Puertas, M.C., Saccomandi, P., Artese, A., et al. (2011). HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029. Paper presented at International Workshop on HIV & Hepatitis virus Drug Resistance and curative strategies, Los Cabos, Mexico.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_86731";s:6:"handle";s:10:"2108/51908";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:160:"HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029";s:9:"metadata6";s:209:"Ceccherini-Silberstein, F; Surdo, M; Alteri, C; Puertas, MC; Saccomandi, P; Artese, A; Balestra, E; Chapman, D; Lewis, M; Valdez, H; Clotet, B; Alcaro, S; Santoro, MM; Svicher, V; Martinez-Picado, J; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:62;a:14:{s:9:"citazione";s:325:"Cento, V., Svicher, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2011). The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_87131";s:6:"handle";s:10:"2108/51956";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:141:"The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing";s:9:"metadata6";s:221:"Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, A; Antinori, A; Andreoni, M; Perno, C; Capobianchi, M; Ceccherini-Silberstein, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:63;a:14:{s:9:"citazione";s:293:"De Luca, A., Di Giambenedetto, S., Maserati, R., Gianotti, N., Narciso, P., Antinori, A., et al. (2011). Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score. ANTIVIRAL THERAPY, 16(4), 489-497 [10.3851/IMP1799].";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_58914";s:6:"handle";s:10:"2108/18076";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:134:"Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score";s:9:"metadata6";s:168:"De Luca, A; Di Giambenedetto, S; Maserati, R; Gianotti, N; Narciso, P; Antinori, A; Di Perri, G; Prosperi, MCF; Baldanti, F; Micheli, V; Zazzi, M; Perno, CF; Santoro, M";s:9:"metadata7";s:15:"10.3851/IMP1799";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:64;a:14:{s:9:"citazione";s:269:"Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2011). The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_87569";s:6:"handle";s:10:"2108/52061";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:85:"The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion";s:9:"metadata6";s:185:"Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf";s:9:"metadata7";s:25:"10.1007/s15010-011-0090-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:65;a:14:{s:9:"citazione";s:309:"Svicher, V., Alteri, C., Artese, A., Forbici, F., Santoro, M.M., Schols, D., et al. (2010). Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 55(3), 336-344 [10.1097/QAI.0b013e3181e6763f].";s:4:"data";s:10:"2010-11-01";s:2:"id";s:19:"PUBBLICAZIONE_35846";s:6:"handle";s:10:"2108/18496";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens";s:9:"metadata6";s:209:"Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, MM; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; Ceccherini-Silberstein, F; Balzarini, J; Perno, CF";s:9:"metadata7";s:28:"10.1097/QAI.0b013e3181e6763f";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:66;a:14:{s:9:"citazione";s:306:"Svicher V, Alteri C, Artese A, Forbici F, Santoro MM, Schols D, et al. (2010). Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 55(3), 336-344 [doi: 10.1097/QAI.0b013e3181e6763f].";s:4:"data";s:7:"2010-11";s:2:"id";s:19:"PUBBLICAZIONE_65645";s:6:"handle";s:10:"2108/19359";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:121:"Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens.";s:9:"metadata6";s:193:"Svicher V; Alteri C; Artese A; Forbici F; Santoro MM; Schols D; Van Laethem K; Alcaro S; Costa G; Tommasi C; Zaccarelli M; Narciso P; Antinori A; Ceccherini-Silberstein F; Balzarini J; Perno CF";s:9:"metadata7";s:33:"doi: 10.1097/QAI.0b013e3181e6763f";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:67;a:14:{s:9:"citazione";s:251:"Zehender, G., Ebranati, E., Lai, A., Santoro, M.M., Alteri, C., Giuliani, M., et al. (2010). Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 55(2), 156-160.";s:4:"data";s:10:"2010-10-01";s:2:"id";s:19:"PUBBLICAZIONE_35841";s:6:"handle";s:10:"2108/18498";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:92:"Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy";s:9:"metadata6";s:130:"Zehender, G; Ebranati, E; Lai, A; Santoro, MM; Alteri, C; Giuliani, M; Palamara, G; Perno, CF; Galli, M; Lo Presti, A; Ciccozzi, M";s:9:"metadata7";s:28:"10.1097/QAI.0b013e3181eb3002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:68;a:14:{s:9:"citazione";s:282:"Tommasi, C., Ceccherini-Silberstein, F., D'Arrigo, R., Bellagamba, R., Tempestilli, M., Dessì, C., et al. (2010). Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 42(3), 237-239.";s:4:"data";s:7:"2010-03";s:2:"id";s:19:"PUBBLICAZIONE_35924";s:6:"handle";s:10:"2108/18400";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:105:"Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir";s:9:"metadata6";s:166:"Tommasi, C; Ceccherini-Silberstein, F; D'Arrigo, R; Bellagamba, R; Tempestilli, M; Dessì, C; Santoro, MM; Forbici, F; Nicastri, E; Pucillo, LP; Perno, CF; Narciso, P";s:9:"metadata7";s:25:"10.3109/00365540903447018";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:69;a:14:{s:9:"citazione";s:335:"Zaccarelli, M., Antinori, A., Cozzi-Lepri, A., Mussini, C., Palamara, G., Santoro, M.M., et al. (2010). Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 53(1), 150-151.";s:4:"data";s:10:"2010-01-01";s:2:"id";s:19:"PUBBLICAZIONE_35929";s:6:"handle";s:10:"2108/18344";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:165:"Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test";s:9:"metadata6";s:146:"Zaccarelli, M; Antinori, A; Cozzi-Lepri, A; Mussini, C; Palamara, G; Santoro, MM; Spagnuolo, V; Monforte, Ad; Perno, CF; Ceccherini-Silberstein, F";s:9:"metadata7";s:28:"10.1097/QAI.0b013e3181c428b4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:70;a:14:{s:9:"citazione";s:269:"Schapiro, J.M., Scherer, J., Boucher, C.A., Baxter, J.D., Tilke, C., Perno, C.F., et al. (2010). Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score. ANTIVIRAL THERAPY, 15(7), 1011-1019.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_35814";s:6:"handle";s:10:"2108/39769";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:134:"Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score";s:9:"metadata6";s:106:"Schapiro, JM; Scherer, J; Boucher, CA; Baxter, JD; Tilke, C; Perno, CF; Maggiolo, F; Santoro, MM; Hall, DB";s:9:"metadata7";s:15:"10.3851/IMP1670";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:71;a:14:{s:9:"citazione";s:331:"Santoro, M., Bertoli, A., Lorenzini, P., Ceccherini-Silberstein, F., Gianotti, N., Mussini, C., et al. (2009). Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients. INFECTION, 37(3), 233-243 [10.1007/s15010-008-8065-4].";s:4:"data";s:7:"2009-06";s:2:"id";s:19:"PUBBLICAZIONE_81714";s:6:"handle";s:10:"2108/47515";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:164:"Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients";s:9:"metadata6";s:218:"Santoro, M; Bertoli, A; Lorenzini, P; Ceccherini-Silberstein, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, C";s:9:"metadata7";s:25:"10.1007/s15010-008-8065-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:72;a:14:{s:9:"citazione";s:219:"Giuliani, M., Montieri, S., Palamara, G., Latini, A., Alteri, C., Perno CF, et al. (2009). Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 25(2), 157-164.";s:4:"data";s:10:"2009-02-24";s:2:"id";s:18:"PUBBLICAZIONE_4316";s:6:"handle";s:10:"2108/39180";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:72:"Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy";s:9:"metadata6";s:105:"Giuliani, M; Montieri, S; Palamara, G; Latini, A; Alteri, C; Perno CF; Santoro, MM; Rezza, G; Ciccozzi, M";s:9:"metadata7";s:21:"10.1089/aid.2008.0175";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:73;a:14:{s:9:"citazione";s:211:"Trignetti, M., Sing, T., Svicher, V., Santoro, M., Forbici, F., D'arrigo, R., et al. (2009). Dynamics of NRTI resistance mutations during therapy interruption. AIDS RESEARCH AND HUMAN RETROVIRUSES, 25(1), 57-64.";s:4:"data";s:7:"2009-01";s:2:"id";s:19:"PUBBLICAZIONE_81719";s:6:"handle";s:10:"2108/47511";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:65:"Dynamics of NRTI resistance mutations during therapy interruption";s:9:"metadata6";s:224:"Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, C; Ceccherini-Silberstein, F";s:9:"metadata7";s:21:"10.1089/aid.2008.0159";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:74;a:14:{s:9:"citazione";s:271:"Santoro, M., Ciccozzi, M., Alteri, C., Montieri, S., Alexiev, I., Dimova, I., et al. (2008). Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria. AIDS RESEARCH AND HUMAN RETROVIRUSES, 24(9), 1133-1138.";s:4:"data";s:7:"2008-09";s:2:"id";s:19:"PUBBLICAZIONE_83924";s:6:"handle";s:10:"2108/28935";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:121:"Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria";s:9:"metadata6";s:129:"Santoro, M; Ciccozzi, M; Alteri, C; Montieri, S; Alexiev, I; Dimova, I; Ceccherini-Silberstein, F; Beshkov, D; Rezza, G; Perno, C";s:9:"metadata7";s:21:"10.1089/aid.2008.0042";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:75;a:14:{s:9:"citazione";s:326:"Svicher, V., Aquaro, S., D'Arrigo, R., Artese, A., Dimonte, S., Alcaro, S., et al. (2008). Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure. THE JOURNAL OF INFECTIOUS DISEASES, 197(10), 1408-1418 [10.1086/587693].";s:4:"data";s:10:"2008-05-15";s:2:"id";s:19:"PUBBLICAZIONE_83932";s:6:"handle";s:10:"2108/28971";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure";s:9:"metadata6";s:217:"Svicher, V; Aquaro, S; D'Arrigo, R; Artese, A; Dimonte, S; Alcaro, S; Santoro, M; Di Perri, G; Caputo, S; Bellagamba, R; Zaccarelli, M; Visco Comandini, U; Antinori, A; Narciso, P; CECCHERINI SILBERSTEIN, F; Perno, Cf";s:9:"metadata7";s:14:"10.1086/587693";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:76;a:14:{s:9:"citazione";s:295:"Santoro, M., Bertoli, A., Lorenzini, P., Lazzarin, A., Esposito, R., Carosi, G., et al. (2008). Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study. AIDS PATIENT CARE AND STDS, 22(1), 7-16 [10.1089/apc.2007.0013].";s:4:"data";s:7:"2008-01";s:2:"id";s:19:"PUBBLICAZIONE_82355";s:6:"handle";s:10:"2108/28934";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:133:"Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study";s:9:"metadata6";s:197:"Santoro, M; Bertoli, A; Lorenzini, P; Lazzarin, A; Esposito, R; Carosi, G; Di Perri, G; Filice, G; Moroni, M; Rizzardini, G; Caramello, P; Maserati, R; Narciso, P; Cargnel, A; Antinori, A; Perno, C";s:9:"metadata7";s:21:"10.1089/apc.2007.0013";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:77;a:14:{s:9:"citazione";s:359:"Ceccherini-Silberstein, F., Svicher, V., Sing, T., Artese, A., Santoro, M., Forbici, F., et al. (2007). Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors. JOURNAL OF VIROLOGY, 81(20), 11507-11519 [10.1128/JVI.00303-07].";s:4:"data";s:7:"2007-10";s:2:"id";s:19:"PUBBLICAZIONE_81713";s:6:"handle";s:10:"2108/45988";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:189:"Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors";s:9:"metadata6";s:190:"Ceccherini-Silberstein, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, C";s:9:"metadata7";s:20:"10.1128/JVI.00303-07";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:78;a:14:{s:9:"citazione";s:308:"Aquaro, S., D'Arrigo, R., Svicher, V., Perri, G., Caputo, S., Visco-Comandini, U., et al. (2006). Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 58(4), 714-722 [10.1093/jac/dkl306].";s:4:"data";s:7:"2006-10";s:2:"id";s:19:"PUBBLICAZIONE_82377";s:6:"handle";s:10:"2108/26959";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:133:"Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment";s:9:"metadata6";s:198:"Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco-Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, C";s:9:"metadata7";s:18:"10.1093/jac/dkl306";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:79;a:14:{s:9:"citazione";s:311:"Svicher, V., Sing, T., Santoro, M., Forbici, F., Rodríguez-Barrios, F., Bertoli, A., et al. (2006). Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. JOURNAL OF VIROLOGY, 80(14), 7186-7198 [10.1128/JVI.02084-05].";s:4:"data";s:7:"2006-07";s:2:"id";s:19:"PUBBLICAZIONE_81726";s:6:"handle";s:10:"2108/43573";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:145:"Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors";s:9:"metadata6";s:205:"Svicher, V; Sing, T; Santoro, M; Forbici, F; Rodríguez-Barrios, F; Bertoli, A; Beerenwinkel, N; Bellocchi, M; Gago, F; d'Arminio Monforte, A; Antinori, A; Lengauer, T; Ceccherini-Silberstein, F; Perno, C";s:9:"metadata7";s:20:"10.1128/JVI.02084-05";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:80;a:14:{s:9:"citazione";s:279:"Santoro, M., Svicher, V., Gori, C., Zaccarelli, M., Tozzi, V., Forbici, F., et al. (2006). Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy. NEW MICROBIOLOGICA, 29(2), 89-100.";s:4:"data";s:7:"2006-04";s:2:"id";s:19:"PUBBLICAZIONE_81724";s:6:"handle";s:10:"2108/43574";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:152:"Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy";s:9:"metadata6";s:210:"Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Tozzi, V; Forbici, F; D'Arrigo, R; Trotta, M; Bellocchi, M; Visco-Comandini, U; Cenci, A; Bertoli, A; Narciso, P; Antinori, A; Perno, C; Ceccherini-Silberstein, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:81;a:14:{s:9:"citazione";s:348:"Ceccherini-Silberstein, F., Gago, F., Santoro, M., Gori, C., Svicher, V., Rodríguez-Barrios, F., et al. (2005). High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations. JOURNAL OF VIROLOGY, 79(16), 10718-10729 [10.1128/JVI.79.16.10718-10729.2005].";s:4:"data";s:7:"2005-08";s:2:"id";s:19:"PUBBLICAZIONE_82024";s:6:"handle";s:10:"2108/42284";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:154:"High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations";s:9:"metadata6";s:189:"Ceccherini-Silberstein, F; Gago, F; Santoro, M; Gori, C; Svicher, V; Rodríguez-Barrios, F; d'Arrigo, R; Ciccozzi, M; Bertoli, A; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Perno, C";s:9:"metadata7";s:34:"10.1128/JVI.79.16.10718-10729.2005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:82;a:14:{s:9:"citazione";s:236:"Santoro, M., Ceccherini-Silberstein, F., Gori, C., Svicher, V., Forbici, F., Bellocchi, M., et al. (2004). Temporal change in the use of genotypic resistance testing over the years 1999--2003. NEW MICROBIOLOGICA, 27(2 Suppl 1), 141-144.";s:4:"data";s:7:"2004-04";s:2:"id";s:19:"PUBBLICAZIONE_82014";s:6:"handle";s:10:"2108/40984";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:84:"Temporal change in the use of genotypic resistance testing over the years 1999--2003";s:9:"metadata6";s:170:"Santoro, M; Ceccherini-Silberstein, F; Gori, C; Svicher, V; Forbici, F; Bellocchi, M; d'Arrigo, R; Bertoli, A; Giannella, S; Trotta, M; Bonfigli, S; Antinori, A; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:83;a:14:{s:9:"citazione";s:346:"Buschini, A., Martino, A., Gustavino, B., Monfrinotti, M., Poli, P., Rossi, C., et al. (2004). Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization. MUTATION RESEARCH. GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 557, 119-129.";s:4:"data";s:4:"2004";s:2:"id";s:17:"PUBBLICAZIONE_775";s:6:"handle";s:10:"2108/30790";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:25:"Settore BIO/18 - Genetica";s:9:"metadata4";N;s:9:"metadata5";s:167:"Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization";s:9:"metadata6";s:107:"Buschini, A; Martino, A; Gustavino, B; Monfrinotti, M; Poli, P; Rossi, C; Santoro, M; Dorr, AJM; Rizzoni, M";s:9:"metadata7";s:30:"10.1016/j.mrgentox.2003.10.008";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }